Ebola | |||||
NEWS | |||||
Should Africa Risk Ebola Drug, Remdesivir as Treatment for Covid-19? Remdesivir was originally developed to treat the Ebola virus disease. While many critics are not against the trail of the drug on Coronavirus patients, they ...
| |||||
Why the WHO, often under fire, has a tough balance to strike in its efforts to address health ... "We know Ebola," as one expert recalled the early stages of response. "This will be manageable." It was not until August 2014, well after the epidemic ...
| |||||
To End Social Distancing, the US Must Dramatically Ramp Up Contact Tracing But people with SARS or Ebola spread the virus only when they're clearly sick, making it easier to identify and isolate cases. COVID-19 is a different ...
| |||||
More than 70 US labs join CDC initiative to study coronavirus genome Gene sequences have also been shared to help track influenza, and experts have used it to better understand Ebola outbreaks in several African ...
| |||||
Coronavirus: Can ubuntu philosophy provide a way to face health crises? Accounts of enforced action to control Ebola and H1N1 suggest that a sense of emergency may override attention to other issues. These include ...
| |||||
Local hospital to give new 'game changing' coronavirus drug Lytle said the intravenous drug was originally developed to treat Ebola. There have been studies in China, Europe and the United States on the drug.
| |||||
'Everyone's excited about it': Bryan experts weigh in on new drug, other COVID-19 treatments It has been used to treat other disease – including Ebola – and is currently available for compassionate use in children and pregnant women. Johnson ...
| |||||
LI hospitals part of clinical trials involving remdesivir, COVID-19 patients Remdesivir has been in development as an anti-viral drug for years and tested on viruses including Ebola and SARS. Credit: Ulrich Perrey / Pool / AFP ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar